We back technologist-turned founders to achieve world-class breakthrough.
We are a China-focused seed and early venture investor since 2006. We pioneered fintech, enterprise software and deeptech investing thesis in China since 2012. We have seeded and backed more than 160 teams with $1.3+ billion currently under management.
We have built a large network of extraordinary founders in China, across enterprise systems, frontier technologies, life sciences as well as consumer evolution themes.
Tiger Brokers is a one-stop destination to trade stocks tailored for global mobile-native investors.
Missfresh invented Distributed Mini Warehouse (DMW) model to operate an integrated online-and-offline on-demand retail business focusing on offering fresh produce and fast-moving consumer goods (FMCGs).
Ezbuy was a benchmark success for cross-border e-commerce in Singapore and is now part of Light In the Box (NASDAQ: LITB), serving in 25 languages across 140 countries globally.
Investing early has always been a key success factor for us. The ability to enter a newly formed industry early enpowered us to become a leader. We all have real industry experience as business operators ourselves with the right skillsets in trend-spotting, pattern recognition and fast decision-making. All of us are deeply involved in deal-sourcing and closing. You get all of us once you get one of us.
We never wanted to be a single-sector investor in China, as we have witnessed the repetitive turmoil of themes for the past twenty years. We decided to mingle sectors within one fund and focused on early stage only. Despite of slight portfolio construct differences between funds, we have always maintained a high percentage in enterprise and technology deals, while staying vigilant to new ideas in life sciences and consumer themes.
We are laser focused on investment discipline. We target a 10X return for each round at the moment of investment, regardless of lead / follow or follow-on strategies. We have also carefully kept our fund size at identical level so that we can keep up our performance through the years.
We only invest in product companies. Be it software, hardware, healthcare or consumer, it has to be a product company as we believe there is a higher possibility of success, if associated with a product format. In those companies, we are actively taking product prototyping risk and Product-Market-Fit (PMF) risk.
We manage $1.3+ billion with 160+ portfolio companies, leading to 5 IPOs and 30+ M&As by the end of 2021.
We focus on industries driven by technology. We help transform technologists into entrepreneurs. We actively take technology and product risks.
Fintech, Tech-fin & Financial Software
Internet of Things
Genetics and Multi-omics
New Modality Therapeutics
Next Generation of Sequencing and AI
Born Global, Live Local
We attracted and promoted partners from internal and our entrepreneur circles only. Some of our interpersonal relationships went back to as early as 2004. The trust is deep and built for the long run.
Bruker Corporation (Nasdaq: BRKR) announced important bioinformatics launches for 4D-Proteomics on the timsTOF platform: A novel de novo sequencing algorithm was developed in collaboration with Rapid Novor Inc., using over 1.7 million PASEF data-points to improve accuracy and speed for immunopeptidomics in real-time.